As the healthcare industry continues to face rising costs and budget restrictions, many organizations are looking for ways to better manage purchasing and supplier relationships.
Moffitt Cancer Center
., (NASDAQ: SQI) a provider of on-demand source-to-settle solutions, to increase contract compliance and improve spend visibility with the SciQuest Spend Director
Moffitt’s mission is to contribute to the prevention and cure of cancer. In addition to providing patient care, the Tampa, Fla.-based cancer center specializes in research and education. Moffitt also boasts the Southeast’s largest blood and marrow transplant program and outpatient treatment programs that record more than 320,500 visits a year.
With SciQuest’s eMarketplace, Moffitt can promote items within its contract portfolio across the entire organization, helping increase overall contract compliance and better control of spending. This enables Moffitt to ensure that it is realizing the maximum value from existing contracts with vendors, driving spending towards pre-negotiated prices.
SciQuest’s on-demand eProcurement software is specifically designed for the complex procurement needs of hospitals and healthcare organizations. The solution is able to handle large volumes of contract and product data that undergo frequent updates, and also ensures that users select and order the right products for the right procedures. Organizations representing more than 130 hospitals have selected SciQuest’s eMarketplace over the last two years. Customers include ROi (Resource Optimization & Innovation, the supply chain arm of Mercy), which is ranked number two on Gartner’s Healthcare Supply Chain Top 25, as well as 10 other healthcare organizations on the Gartner list.
“Our core mission is to provide stellar patient care as we work tirelessly to find a cure for a disease that affects millions every year. With every purchase we make, the SciQuest solution helps drive savings on our spend, all while freeing up our staff so it can focus on improving patient care as we strive toward a cure for cancer,” said John Efthemis, interim director of material management, Moffitt.